SCHEMBL8144459

SCHEMBL8144459

Nc1ccc(C(=O)Cn2ccnc2)cc1[N+](=O)[O-]

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP19A1 P11511 5/20 0.69
▸ ALPG P10696 2/20 0.57
▸ ALPI P09923 1/20 0.57
▸ TDP1 Q9NUW8 1/20 0.57
▸ PLAA Q9Y263 1/20 0.57
▸ L3MBTL1 Q9Y468 1/20 0.57
▸ CYP11B1 P15538 1/20 0.54
▸ CYP11B2 P19099 1/20 0.54
▸ CA12 O43570 1/20 0.52
▸ CA1 P00915 1/20 0.52
▸ CA2 P00918 1/20 0.52
▸ CA3 P07451 1/20 0.52
▸ CA4 P22748 1/20 0.52
▸ CA6 P23280 1/20 0.52
▸ CA5A P35218 1/20 0.52
▸ CA7 P43166 1/20 0.52
▸ CA9 Q16790 1/20 0.52
▸ CA13 Q8N1Q1 1/20 0.52
▸ CA14 Q9ULX7 1/20 0.52
▸ CA5B Q9Y2D0 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5730977 0.82 CYP19A1 (1.00) CYP19A1ALPGALPITDP1PLAA
SCHEMBL76457 0.81 EGFR (0.51) CYP19A1CA12CA1CA2CA9
Hydrochloric Acid SCHEMBL410676 0.81 CYP19A1 (0.97) CYP19A1ALPGALPITDP1PLAA
SCHEMBL7115992 0.80 CYP19A1 (0.72) CYP19A1ALPGALPITDP1PLAA
SCHEMBL20033132 0.80 CYP19A1 (0.58) CYP19A1ALPGALPITDP1PLAA
Hydrochloric Acid SCHEMBL7251569 0.78 ALPG (0.60) CYP19A1ALPGALPITDP1PLAA
SCHEMBL9663730 0.76 CYP19A1 (1.00) CYP19A1ALPGALPITDP1PLAA
SCHEMBL11239175 0.74 CYP19A1 (0.60) CYP19A1CYP11B1CYP11B2CA12
SCHEMBL27559825 0.74 CYP19A1 (0.79) CYP19A1ALPGALPITDP1PLAA
SCHEMBL11714136 0.73 L3MBTL1 (0.64) TDP1L3MBTL1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0556393-B1 FUSED PYRAZINE DERIVATIVE YAMANOUCHI PHARMA CO LTD (JP) 2000-07-26 — — EP disclosed
US-5283244-A Anticonvulsants, nervous system disorders YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1994-02-01 — — US disclosed
EP-0556393-A1 FUSED PYRAZINE DERIVATIVE YAMANOUCHI PHARMACEUTICAL CO. LTD. (JP) 1993-08-25 — — EP disclosed
Send feedback